ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 226,26
1,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Defence Therapeutics Inc (QB) (DTCFF)

  7. Defence Therapeutics Inc (QB) (DTCFF) Actualités

DTCFF

Defence Therapeutics (QB) (DTCFF)

Defence Therapeutics Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:DTCFF
DateHeureSourceTitreSymboleSociété
16/02/202216h00InvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
26/01/202214h49InvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9USOTC:DTCFFDefence Therapeutics Inc (QB)
30/11/202118h32InvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTUSOTC:DTCFFDefence Therapeutics Inc (QB)
23/11/202114h24InvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
09/11/202117h50InvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSUSOTC:DTCFFDefence Therapeutics Inc (QB)
03/11/202113h11InvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSUSOTC:DTCFFDefence Therapeutics Inc (QB)
13/10/202115h15InvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
06/10/202115h32InvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMAUSOTC:DTCFFDefence Therapeutics Inc (QB)
29/09/202114h30InvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
20/09/202116h01InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSUSOTC:DTCFFDefence Therapeutics Inc (QB)
14/09/202114h13InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELUSOTC:DTCFFDefence Therapeutics Inc (QB)
07/09/202113h35InvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDUSOTC:DTCFFDefence Therapeutics Inc (QB)
01/09/202116h39InvestorsHub NewsWireThe vaccination specialist is about to become popularUSOTC:DTCFFDefence Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:DTCFF

Dernières Valeurs Consultées

LSE
0XI6
LSE
1015
NYSE
PLYM
Plymouth Industrial REIT
ASX
CIW
Clime Investment Managem...
BIT
F16095
Vontobel Financial Produ...
COIN
NVAAUSD
Neeva
NASDAQ
NDSN
Nordson
LSE
01IT
Rec 23 A
BOV
RAILG272
RAILG272 Ex:27,16
COIN
SWAPUSD
BSTP
GODSUSD
Gods Unchained
BOV
P1SX34Q
Phillips 66
USOTC
JROOF
Jericho Energy Ventures (PK)
COIN
XT3GBP
COIN
ADLPUSD
COIN
MMUST
Million
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés